Jianhua Ji

No ORCID on file · 1 paper in corpus

lab-animal 2026

Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis

Frontiers in oncology ·doi:10.3389/fonc.2026.1784356

INTRODUCTION: Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor-positive breast cancer; however, its partial estrogen agonist activity in the endometrium predisposes patients to hyperplasia and, in some cases, malignant …